Endocrine Clinical Trials

• Endocrine Studies in Health and Disease
  ClinicalTrials.gov Identifier: NCT00006073 - Recruiting
  Endocrine Diseases
  
• Evaluation of Women with Endocrine and Reproductive-Related Conditions
  ClinicalTrials.gov Identifier: NCT00001850 - Recruiting
  Endocrine Disease; Infertility
  
• Study of Lanreotide Autogel in Non-Functioning Entero-Pancreatic Endocrine Tumours
  ClinicalTrials.gov Identifier: NCT00353496 - Recruiting
  Endocrine Tumors
  
• Randomized Controlled Trial on Radiotherapy +/- Endocrine Therapy for PSA Failure After Radical Prostatectomy (JCOG0401)
  ClinicalTrials.gov Identifier: NCT00138008 - Recruiting
  Prostate Cancer
  
• Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
  ClinicalTrials.gov Identifier: NCT00058071 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; neurotoxicity
  
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
  ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
  ovarian epithelial cancer
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Evaluation of Patients with Endocrine-Related Conditions
  ClinicalTrials.gov Identifier: NCT00005664 - Recruiting
  Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; ...
  
• SPECT/CT in Endocrine and Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00230139 - Recruiting
  Endocrine and Neuroendocrine Tumors
  
• Studies of Inherited Diseases of Metabolism
  ClinicalTrials.gov Identifier: NCT00001345 - Recruiting
  Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia
  
• Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
  ClinicalTrials.gov Identifier: NCT00082654 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma; psychosocial effects and treatment
  
• Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00003938 - Active, not recruiting
  Kidney Disease; Breast Cancer; Endocrine Cancer; Gastrointestinal Cancer; Hematopoietic and Lymphoid Cancer; Central Nervous System Cancer
  
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
  adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
  
• Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
  stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
  
• Genetic Investigation of Pediatric Tumors of the Pituitary Gland
  ClinicalTrials.gov Identifier: NCT00001595 - Recruiting
  Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00014586 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• NGR-TNF in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00098943 - Active, not recruiting
  adult solid tumor; Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer
  
• Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
  ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
  recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems
  ClinicalTrials.gov Identifier: NCT00369876 - Active, not recruiting
  Burns; Anorexia
  
• Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00109993 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Genetics of Endocrine Tumours
  ClinicalTrials.gov Identifier: NCT00461188 - Recruiting
  Acromegaly
  
• Endocrine and Psychological Evaluation of Adopted Children
  ClinicalTrials.gov Identifier: NCT00368043 - Recruiting
  Psychosocial Adjustment
  
• Psychosocial Aspects of MEN Syndromes
  ClinicalTrials.gov Identifier: NCT00501449 - Recruiting
  Multiple Endocrine Neoplasia
  
• Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00104715 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients
  ClinicalTrials.gov Identifier: NCT00447785 - Recruiting
  Alcoholism
  
• Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00062348 - Recruiting
  Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer
  
• Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00066690 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
  ClinicalTrials.gov Identifier: NCT00345800 - Recruiting
  Narcolepsy With Cataplexy
  
• A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
  ClinicalTrials.gov Identifier: NCT00448136 - Recruiting
  Neoplasms
  
• Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer
  ClinicalTrials.gov Identifier: NCT00060372 - Recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00110162 - Recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs
  ClinicalTrials.gov Identifier: NCT00245531 - Recruiting
  Human Immunodeficiency Virus Positive or Negative
  
• Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00504218 - Recruiting
  Hypopituitarism; Hypogonadism; Thyroid Dysfunction; Bone Diseases, Metabolic
  
• Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis
  ClinicalTrials.gov Identifier: NCT00187824 - Recruiting
  Sepsis; Critical Illness
  
• Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00066586 - Active, not recruiting
  Breast Cancer
  
• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Vandetanib in Treating Young Patients With Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00514046 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
  Breast Cancer
  
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00390325 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002720 - Active, not recruiting
  stage I breast cancer
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Letrozole With or Without Tipifarnib in Treating Women With Locally Advanced, Locally Recurrent, or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00060177 - Active, not recruiting
  Breast Cancer
  
• Tissue Procurement for Scientific Study
  ClinicalTrials.gov Identifier: NCT00182858 - Recruiting
  Cardiovascular Diseases; Cancer; Endocrine Diseases; Neurological Disorders; Arthritis; Mental Disorders
  
• Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00525161 - Recruiting
  Breast Cancer
  
• Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00375752 - Recruiting
  Breast Neoplasms
  
• Genetic Study of Patients With Inherited Urologic Malignancies
  ClinicalTrials.gov Identifier: NCT00019617 - Recruiting
  Birt Hogg Dube Syndrome; Kidney Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Von Hippel-Lindau Syndrome
  
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003449 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
  ClinicalTrials.gov Identifier: NCT00114270 - Active, not recruiting
  Breast Cancer; Osteoporosis
  
• Bone Metabolism and PTHrP Lactation Study
  ClinicalTrials.gov Identifier: NCT00430417 - Recruiting
  Pregnancy; Lactation; Bone Diseases, Endocrine
  
• Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
  ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer
  
• Endocrine Studies of Healthy Children
  ClinicalTrials.gov Identifier: NCT00001195 - Recruiting
  Healthy
  
• Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003278 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00053898 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Combination Chemotherapy in Treating Women With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00027859 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002528 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002777 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00032136 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003682 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002606 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
  
• Treatment of Zollinger-Ellison Syndrome With Prevacid
  ClinicalTrials.gov Identifier: NCT00204373 - Recruiting
  Zollinger-Ellison Syndrome; Multiple Endocrine Neoplasia
  
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00131924 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Exemestane and Raloxifene in Treating Postmenopausal Women With a History of Ductal Carcinoma in Situ, Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004247 - Active, not recruiting
  Breast Cancer; breast cancer in situ
  
• Chemotherapy Plus Surgery in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003013 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00080743 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Tamoxifen in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003678 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006044 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
  stage II prostate cancer; stage I prostate cancer
  
• Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009945 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
  ClinicalTrials.gov Identifier: NCT00452140 - Recruiting
  Metastatic Breast Cancer; Advanced Breast Cancer
  
• Anastrozole With or Without Trastuzumab in Treating Postmenopausal Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022672 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002679 - Active, not recruiting
  Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer
  
• Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00126464 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00090844 - Active, not recruiting
  Drug Toxicity; hormonal changes; stage I breast cancer; stage II breast cancer
  
• Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003679 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
  
• Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00057941 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
  recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
  ClinicalTrials.gov Identifier: NCT00016432 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
  ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
  ClinicalTrials.gov Identifier: NCT00077168 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003418 - Active, not recruiting
  stage III breast cancer; stage I breast cancer; stage II breast cancer
  
• ICI 182780 in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue